A. Spanevello (Tradate, Italy)
Urinary LTE4 is increased proportionally to asthma severity in steroid-treated patients vs healthy controls
C. Micheletto, M. P. Visconti, S. Tognella, F. Trevisan, C. Pomari, R. W. Dal Negro (Bussolengo, Italy)
|  |
Nitric oxide metabolites in exhaled breath condesate in patients with pollen allergy and bronchial asthma
S. K. Soodaeva, I. A. Klimanov, A. G. Chuchalin (Moscow, Russia)
| |
The role of topical nasal steroids (TNS) in the treatment of bronchial asthma (BA) combined with nasal polyposis (NP)
I. I. Vorjeva, L. B. Sekretareva, B. A. Chernyak (Irkutsk, Russia)
| |
Effect of adding montelukast to budesonide treatment on exhaled nitric oxide in mild to moderate asthma
I. V. Korzh, V. D. Nemtsova, I. F. Fedotova (Kharkov, Ukraine)
| |
Exhaled nitric oxide is related to asthma control but not severity
T. K. Lim, L. K. Tan, K. L. Khoo, S. M. Khoo, G. Chua (Singapore, Singapore)
| |
Overweight and severe asthma
B. G. Laurence, F. Serge, M. Christophe, G. Bruno, P. Sandrine, D. Alain (Toulouse, Osseja, France)
| |
Exercise induces dyspnoea among elite athletes - is it always asthma?
V. Backer, E. Fritzboeger, S. Winther, K. R. Larsen (Copenhagen, Denmark)
| |
Bronchial asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study
G. Caramori, M. Fabbri, D. Paioli, F. Falcone, C. Severino, G. Felisatti, O. Arar, I. M. Adcock, K. F. Chung, P. J. Barnes, A. Papi, A. Ciaccia (Ferrara, Bologna, Italy; London, United Kingdom)
| |
Comparison of a formoterol multiple dose dry powder inhaler (MDPI) with a formoterol single dose dry powder inhaler (SDPI) in patients with moderate to severe asthma
G. Kunkel, P. Metzenauer, S. Hoesch, A. K. Bielert (Berlin, Munich, Germany)
| |
A long term randomized clinical study of 300 asthmatics. An internet based asthma monitoring tool improves quality of life significantly
L. Rasmussen, K. Phanareth, H. Nolte, V. Backer (Copenhagen, Denmark)
| |
The spectrum of upper airway problems in a problem asthma clinic – the role of the nose
A. E. Stanton, G. W. McGarry, R. Carter, C. E. Bucknall (Glasgow, United Kingdom)
| |
The spectrum of upper airway problems in a problem asthma clinic – the role of the larynx
A. E. Stanton, K. MacKenzie, R. Carter, C. E. Bucknall (Glasgow, United Kingdom)
| |
Physiological evaluation of the upper airway in a problem asthma clinic
A. E. Stanton, M. K. Johnson, R. Carter, K. MacKenzie, C. E. Bucknall (Glasgow, United Kingdom)
| |
High dose inhaled fluticasone propionate and the hypothalamic-pituitary-adrenal axis in asthmatic patients with severe airflow obstruction
D. K. C. Lee, C. E. Bates, B. J. Lipworth (Dundee, United Kingdom)
| |
Efficacy of formoterol and beclomethasone dry powder capsules in asthmatic patients sub-optimally controlled with the fixed combination formoterol-budesonide (ALLIANCE study)
M. Molimard, V. Le Gros, I. Bourdeix (Bordeaux, Rueil-Malmaison, France)
| |
Salmeterol/fluticasone propionate combination (SFC) improves airways hyperresponsiveness (AHR), lung function and symptoms in adult patients with mild asthma
P. Howarth, L. Hewitt, A. Woodcock, L. Rice, C. Whitehead, J. Smith (Southampton, Manchester, Uxbridge, United Kingdom)
| |
Asthma and nasal polyposis: comparative evaluation of serum TNF-α and IL-4
N. V. Chichkova, S. I. Ovcharenko, R. A. Belickaya, G. F. Vasilenko, N. A. Lakshina (Moscow, Russia)
| |
Hospital costs in asthma, chronic obstructive lung disease and pneumonia in a chest clinic of Istanbul University
U. Cenik, C. Cuhadaroglu, H. Issever, F. Erkan (Istanbul, Turkey)
| |
The frequency and the types of arrhythmies of the patients who suffer from COPD and have the disorder if the respiratory gases in the arterial blood
J. Canic, S. Petrovic, V. Canic, M. Milenkovic (Sokobanja, Serbia & Montenegro)
| |
Asthma and nasal polyposis: comparative evaluation of serum TNF-α and IL-4
N. V. Chichkova, S. I. Ovcharenko, R. A. Belickaya, G. F. Vasilenko, N. A. Lakshina (Moscow, Russia)
| |